L K Vujcic - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

AIDS Research and Human Retroviruses|July 1, 1995

Preparation and characterization of human HIV type 1 neutralizing reference seraL K Vujcic, G V Quinnan

The Journal of Infectious Diseases|October 1, 1988

Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulationE C Cooper, L K Vujcic, G V Quinnan

Journal of Virology|August 8, 1998

Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopesE J Park, L K Vujcic, R Anand, et al.

Pediatrics|September 1, 1983

Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assaysY Asano, P Albrecht, L K Vujcic, et al.

Journal of Clinical Microbiology|November 1, 1982

Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virusJ P Iltis, G A Castellano, P Gerber, et al.

Cellular Immunology|June 1, 1990

CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infectionO Shapira-Nahor, H Golding, L K Vujcic, et al.

Annals of Internal Medicine|September 1, 1987

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletionA E Wittek, M A Phelan, M A Wells, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1990

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and AfricansD A Katzenstein, L K Vujcic, A Latif, et al.

AIDS Research and Human Retroviruses|October 11, 1991

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the AmericasE W Carrow, L K Vujcic, W L Glass, et al.

AIDS Research and Human Retroviruses|March 11, 1990

Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

AIDS Research and Human Retroviruses|July 1, 1995

Preparation and characterization of human HIV type 1 neutralizing reference seraL K Vujcic, G V Quinnan

The Journal of Infectious Diseases|October 1, 1988

Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulationE C Cooper, L K Vujcic, G V Quinnan

Journal of Virology|August 8, 1998

Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopesE J Park, L K Vujcic, R Anand, et al.

Pediatrics|September 1, 1983

Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assaysY Asano, P Albrecht, L K Vujcic, et al.

Journal of Clinical Microbiology|November 1, 1982

Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virusJ P Iltis, G A Castellano, P Gerber, et al.

Cellular Immunology|June 1, 1990

CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infectionO Shapira-Nahor, H Golding, L K Vujcic, et al.

Annals of Internal Medicine|September 1, 1987

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletionA E Wittek, M A Phelan, M A Wells, et al.

Journal of Acquired Immune Deficiency Syndromes|January 1, 1990

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and AfricansD A Katzenstein, L K Vujcic, A Latif, et al.

AIDS Research and Human Retroviruses|October 11, 1991

High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the AmericasE W Carrow, L K Vujcic, W L Glass, et al.

AIDS Research and Human Retroviruses|March 11, 1990

Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.

Pageof 1